400 related articles for article (PubMed ID: 2600603)
1. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
[TBL] [Abstract][Full Text] [Related]
2. Effects of tumor necrosis factor on PMN chemotaxis, chemiluminescence, and elastase activity.
Yonemaru M; Stephens KE; Ishizaka A; Zheng H; Hogue RS; Crowley JJ; Hatherill JR; Raffin TA
J Lab Clin Med; 1989 Dec; 114(6):674-81. PubMed ID: 2592855
[TBL] [Abstract][Full Text] [Related]
3. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis.
Harvath L; Balke JA; Christiansen NP; Russell AA; Skubitz KM
J Immunol; 1991 Feb; 146(3):949-57. PubMed ID: 1671052
[TBL] [Abstract][Full Text] [Related]
4. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
Charo IF; Yuen C; Perez HD; Goldstein IM
J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
[TBL] [Abstract][Full Text] [Related]
5. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
Elsner J; Oppermann M; Kapp A
Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
[TBL] [Abstract][Full Text] [Related]
6. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
[TBL] [Abstract][Full Text] [Related]
7. Role of granulocytes and C5a in myocardial response to zymosan-activated serum.
Stahl GL; Fletcher MP; Amsterdam EA; Longhurst JC
Am J Physiol; 1991 Jul; 261(1 Pt 2):H29-37. PubMed ID: 1677537
[TBL] [Abstract][Full Text] [Related]
8. Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis--measurement of lucigenin-dependent chemiluminescence.
Kapp A; Schöpf E
Acta Derm Venereol; 1986; 66(4):285-9. PubMed ID: 2430396
[TBL] [Abstract][Full Text] [Related]
9. Synergism between zymosan-activated serum and heparin in the induction of polymorphonuclear leukocyte aggregation.
Berliner S; Fishelson Z; Wasserman L; Pinkhas J; Aronson M
Biomed Pharmacother; 1988; 42(1):69-72. PubMed ID: 3408808
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
Marder SR; Chenoweth DE; Goldstein IM; Perez HD
J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
12. Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients.
Lewis SL; Van Epps DE; Chenoweth DE
Clin Nephrol; 1988 Aug; 30(2):63-72. PubMed ID: 2846218
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of monoclonal antibodies (mAbs) against human polymorphonuclear (PMN) adherence antigens.
Pham Huu T; Chollet-Martin S; Perianin A; Amit N; Debre P; Hakim J
Biomed Pharmacother; 1987; 41(6):344-9. PubMed ID: 2451544
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.
Van Epps DE; Garcia ML
J Clin Invest; 1980 Aug; 66(2):167-75. PubMed ID: 6249846
[TBL] [Abstract][Full Text] [Related]
15. Effect of temperature on polymorphonuclear leukocyte function.
Johansen KS; Berger EM; Repine JE
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):355-9. PubMed ID: 6324534
[TBL] [Abstract][Full Text] [Related]
16. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
Movat HZ; Rettl C; Burrowes CE; Johnston MG
Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
[TBL] [Abstract][Full Text] [Related]
17. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of C5a-induced actin polymerization, chemotaxis, and phagocytosis of human polymorphonuclear neutrophils incubated in a glucose-based dialysis solution.
Dobos GJ; Andre M; Böhler J; Norgauer J; Lubrich-Birkner I; Steinhauer HB; Schollmeyer PJ
Adv Perit Dial; 1993; 9():307-11. PubMed ID: 8105951
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 inhibits the chemotaxis of human polymorphonuclear neutrophils in vitro.
Baseras B; Gaida MM; Kahle N; Schuppel AK; Kathrey D; Prior B; Wente M; Hänsch GM
Immunobiology; 2012 Jan; 217(1):83-90. PubMed ID: 21899917
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody inhibiting human neutrophil chemotaxis and degranulation.
Cotter TG; Spears P; Henson PM
J Immunol; 1981 Oct; 127(4):1355-60. PubMed ID: 6268706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
